Science | Page 28 of 29

Study Shows Vinegar Reduces Blood Glucose Levels

A new study shows vinegar reduces post-meal hyperglycemia in type 1 diabetics. While previous studies have shown that vinegar improves insulin sensitivity in healthy or insulin-resistant subjects, information on the effect of vinegar in type 1 diabetes has been absent....

New research may hold key to future type 1 diabetes cure

JDRF announced that research financed by JDRF may hold a key component for a possible type 1 diabetes cure. The researchers at the Salk Institute for Biological Studies in California found that a hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas. The researchers found that the stress...

Mechanism Leading to Diabetic Blindness Identified

Diabetic retinopathy is a common side effect of diabetes and the leading cause of blindness in young adults in the United States. Scientists have long known that high blood sugar levels damage blood vessels in the eye, but they didn't know why or how this happens. Now a Michigan State University scientist has...

Swedish Company, Diamyd Medical AB, Plans to Have Diabetes Vaccine by 2011

Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, announced it plans to file the Diamyd® diabetes vaccine for market approval in 2011...

Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes

Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris.

FDA Clears Clibra’s Insulin Patch

Calibra Medical Inc., formerly known as Seattle Medical Technologies Inc., announced today that the U.S. Food and Drug Administration has given Finesse, the company’s insulin patch-pen, 510(k) clearance. Only 2” long, 1” wide and ¼” thick, Finesse is able to hold and deliver prescribed amounts of insulin over multiple days while...

The First Step Toward An Artificial Pancreas: An Interview With Aaron Kowalski

We’re talking about a semi-closed loop system that would automatically dose insulin some of the time. It would be the first system ever to do so...

JDRF and Johnson & Johnson Team Up to Develop “Artificial Pancreas”

The Juvenile Diabetes Research Foundation announced it had teamed up Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease - the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial pancreas...

JDRF Announces Diabetes Research Program with Johnson & Johnson

The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes...

FDA Approves Diamyd Vaccine Study In Children As Young As 3

Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, reports today that the US FDA has approved the experimental use of Diamyd® vaccine in children as young as 3 years of age in the TrialNet GAD study, enrolling 126 new onset type 1 diabetes patients in North America...